Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +395.1% | +106.5% | 2 / 3 | -89.3% | -39.64 pp | +53.23 pp | +2.5% | 0.04 | 21.85 | 0,5 | −89,3% | 0,3 | +395,1% | 21.85 | 36.56 | −40,2% |
| Pts | 12 | 12 | 8 | 0 | 0 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 6.100 (close price on 2026-10-19)EPS (TTM): 279,2
Financial charts
1.Revenue & growth
VND bn0,48Q2/26
1.Revenue & growth
VND bn0,48Q2/26
2.Profit & growth
VND bn0,26Q2/26
3.Profit mix (Penman)
VND bn1,35Q2/26
4.Margins & cost structure
%69.2%Q2/26
5.Returns & cash cycle
% · days-4.4%Q2/26
6.Earnings quality & cash
VND bn-9,25Q2/26
7.Asset structure
VND bn48,3Q2/26
8.Funding & debt health
VND bn · times48,3Q2/26
9.Revenue backlog
VND bn0,17Q2/26
10.Valuation
times · %21,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %65Q2/26
Adjusted EPS growth, latest quarter
395%
Average adjusted EPS growth, 3 quarters
106%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26